Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

Preclinical dose assessment of (S)-(-)-[18F]fluspidine and (R)-(+)-[18F]fluspidine, new PET tracers for imaging of σ1 receptors

Mathias Kranz, B. Sattler, Winnie Deuther-Conrad, S. Fischer, Achim Hiller, C. Donat, B. Wünsch, Jörg Steinbach, Osama Sabri and P. Brust
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1028;
Mathias Kranz
1Dept. of Neuroradiopharmaceuticals, Radiopharmaceutical Cancer Research, Helmholtz-Center Dresden-Rossendorf, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Sattler
2Dept. of Nuclear Medicine, University of Leipzig, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winnie Deuther-Conrad
1Dept. of Neuroradiopharmaceuticals, Radiopharmaceutical Cancer Research, Helmholtz-Center Dresden-Rossendorf, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Fischer
1Dept. of Neuroradiopharmaceuticals, Radiopharmaceutical Cancer Research, Helmholtz-Center Dresden-Rossendorf, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Achim Hiller
1Dept. of Neuroradiopharmaceuticals, Radiopharmaceutical Cancer Research, Helmholtz-Center Dresden-Rossendorf, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Donat
1Dept. of Neuroradiopharmaceuticals, Radiopharmaceutical Cancer Research, Helmholtz-Center Dresden-Rossendorf, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Wünsch
3Pharmaceutical and Medicinal Chemistry, University Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jörg Steinbach
1Dept. of Neuroradiopharmaceuticals, Radiopharmaceutical Cancer Research, Helmholtz-Center Dresden-Rossendorf, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osama Sabri
2Dept. of Nuclear Medicine, University of Leipzig, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Brust
1Dept. of Neuroradiopharmaceuticals, Radiopharmaceutical Cancer Research, Helmholtz-Center Dresden-Rossendorf, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 1028

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Mathias Kranz1,
  2. B. Sattler2,
  3. Winnie Deuther-Conrad1,
  4. S. Fischer1,
  5. Achim Hiller1,
  6. C. Donat1,
  7. B. Wünsch3,
  8. Jörg Steinbach1,
  9. Osama Sabri2 and
  10. P. Brust1
  1. 1Dept. of Neuroradiopharmaceuticals, Radiopharmaceutical Cancer Research, Helmholtz-Center Dresden-Rossendorf, Leipzig, Germany
  2. 2Dept. of Nuclear Medicine, University of Leipzig, Leipzig, Germany
  3. 3Pharmaceutical and Medicinal Chemistry, University Münster, Münster, Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014500
Apr 2015200
Jun 2015100
Jul 2015300
Sep 2015900
Nov 2015100
Dec 2015200
Feb 2016300
Mar 2016600
May 2016300
Jun 20161500
Jul 2016100
Aug 2016300
Sep 2016300
Dec 2016200
Jan 2017500
Feb 2017400
Mar 2017300
Apr 2017300
May 2017500
Jun 2017300
Jul 2017300
Sep 2017300
Oct 2017200
Jan 2018100
Feb 2018200
Apr 2018300
May 2018300
Jun 2018100
Jul 2018100
Aug 2018100
Sep 2018100
Nov 2018100
Jan 20194200
Feb 2019400
Mar 2019100
Apr 2019100
May 2019100
Jun 2019100
Sep 2019300
Oct 2019600
Nov 2019700
Dec 2019800
Jan 2020700
Feb 20201200
Mar 20202900
Apr 20204300
May 20201500
Jun 20201700
Jul 2020500
Aug 20201800
Sep 2020700
Oct 20202400
Nov 2020700
Dec 20202100
Jan 20211000
Feb 20212700
Mar 20211200
Apr 20212300
May 20211300
Jun 2021900
Jul 2021300
Aug 2021600
Sep 20211300
Oct 20211000
Nov 20212200
Dec 20211300
Jan 2022500
Feb 20221200
Mar 2022300
Apr 2022900
May 20221200
Jun 20221400
Jul 20221000
Aug 20221700
Sep 2022300
Oct 2022800
Nov 2022700
Dec 2022300
Jan 2023200
Feb 2023100
Mar 2023200
Apr 2023100
May 2023400
Jun 2023200
Jul 2023400
Aug 2023100
Sep 2023300
Oct 2023300
Nov 2023100
Dec 2023700
Jan 2024900
Feb 2024200
Mar 2024200
Apr 20241000
May 2024700
Jun 2024200
Jul 20244800
Aug 20244600
Sep 2024300
Nov 2024200
Dec 2024200
Feb 2025400
Mar 2025300
Apr 2025400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical dose assessment of (S)-(-)-[18F]fluspidine and (R)-(+)-[18F]fluspidine, new PET tracers for imaging of σ1 receptors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preclinical dose assessment of (S)-(-)-[18F]fluspidine and (R)-(+)-[18F]fluspidine, new PET tracers for imaging of σ1 receptors
Mathias Kranz, B. Sattler, Winnie Deuther-Conrad, S. Fischer, Achim Hiller, C. Donat, B. Wünsch, Jörg Steinbach, Osama Sabri, P. Brust
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1028;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preclinical dose assessment of (S)-(-)-[18F]fluspidine and (R)-(+)-[18F]fluspidine, new PET tracers for imaging of σ1 receptors
Mathias Kranz, B. Sattler, Winnie Deuther-Conrad, S. Fischer, Achim Hiller, C. Donat, B. Wünsch, Jörg Steinbach, Osama Sabri, P. Brust
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1028;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • Nonradioactive analytical methods for quantifying the modification ratio of antibody chelator conjugates (ACCs) with deferroxamine and DOTA
  • SPECT and micro-CT imaging of an extremity leg-injury rat model
  • Rapid Ge-68 breakthrough testing for 68Ge/68Ga portable generators
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Special MTA: Dosimetry Posters

  • Radioimmunotherapy with 90Y-DOTA-BC8 (anti-CD45 Antibody): Effect of Spleen Size and Uptake on Bone Marrow Absorbed Dose
  • New fetal doses from 18FDG administered during pregnancy: standardization of dose calculations and estimations with voxel-based anthropomorphic phantoms
  • IDAC star -a standalone program to easy create Monte Carlo voxel simulated customized dose estimations
Show more Special MTA: Dosimetry Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire